Evidence map›Paper›PMID 23317558›Full record

ArticleClinical colorectal cancer2013

Comparison of dietary and lifestyle habits among stage III and metastatic colorectal cancer patients: findings from CALGB 89803 and CALGB 80405.

Katherine Van Loon, Devin Wigler, Donna Niedzwiecki, Alan P Venook, Charles Fuchs, Charles Blanke, Leonard Saltz, Richard M Goldberg, Jeffrey A Meyerhardt

Open access · greenAbstract read
In one paragraph

Article in Clinical colorectal cancer, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Biological factors driving colorectal cancer metastasis.World journal of gastrointestinal oncology · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Body weight changes in patients undergoing chemotherapy for ovarian cancer influence progression-free and overall survival.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2017
    Article
  14. Dietary habits changes and quality of life in patients undergoing chemotherapy for epithelial ovarian cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 2 countries.

Katherine Van LoonHelen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94115, USA. katherine.vanloon@ucsf.edu
Devin Wigler
Donna Niedzwiecki
Alan P Venook
Charles Fuchs
Charles Blanke
Leonard Saltz
Richard M Goldberg
Jeffrey A Meyerhardt
Dana-Farber Cancer Institute · USUCSF Helen Diller Family Comprehensive Cancer Center · USBC Cancer Agency · CADuke University · USHarvard University · USMemorial Sloan Kettering Cancer Center · USThe Ohio State University · US

Funding

CANCER AND LEUKEMIA GROUP B MINORITY SATELLITE SUPPLEMENU10CA031946 · NCI · UNIVERSITY OF CHICAGO · PI BERTAGNOLLI, MONICA M · 1985 to 2013
$158.4M
Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Monica Gandhi · 1988 to 2026
$93.6M
CANCER &LEUKEMIA GROUP B STATISTICAL CENTERU10CA033601 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI SARGENT, DANIEL J. · 1985 to 2013
$69.4M
Tissue and Pathology ResourcesP50CA127003 · NCI · DANA-FARBER CANCER INST · PI SICINSKA, · 2007 to 2023
$33.2M
UCSF Liver Core CenterP30DK026743 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Holger Willenbring · 1986 to 2026
$30.7M
Dietary And Lifestyle Determinants Of Colon Cancer Recurrence and SurvivalR01CA118553 · NCI · YALE UNIVERSITY · PI FUCHS, CHARLES S · 2007 to 2019
$4.4M
Impact of Celecoxib and Inflammation on Survival in Stage III Colon CancerR01CA169141 · NCI · YALE UNIVERSITY · PI FUCHS, CHARLES S · 2013 to 2018
$3.9M
The Influence of Diet and Lifestyle on Patients with Advanced Colorectal CancerR01CA149222 · NCI · DANA-FARBER CANCER INST · PI MEYERHARDT, JEFFREY A · 2010 to 2014
$2.4M
NCI NIH HHS CA31946NCI NIH HHS CA33601NCI NIH HHS P50 CA127003NCI NIH HHS R01 CA118553NCI NIH HHS R01CA118553NCI NIH HHS R01CA14922NCI NIH HHS R01 CA149222NCI NIH HHS R01 CA169141NCI NIH HHS U10 CA031946NCI NIH HHS U10 CA033601NIAID NIH HHS P30 AI027763NIDDK NIH HHS P30 DK026743
6 · The paper itself

Abstract

unlabelledSelf-administered questionnaires were completed by patients undergoing chemotherapy for stage III colon cancer (n=1095) and metastatic colorectal cancer (n=875). We describe the prevalence of a wide-range of health-related dietary patterns and lifestyle behaviors among colorectal cancer patients with stage III and metastatic disease and report notable similarities in these 2 cohorts.

backgroundCancer patients often pursue lifestyle and dietary changes with the aim to improve outcomes. Using data from 2 large National Cancer Institute-sponsored clinical trials, we report on the dietary and lifestyle practices of patients receiving therapy for stage III colon or metastatic colorectal cancer. PATIENTS AND

methodsSelf-administered questionnaires were completed by patients undergoing chemotherapy for stage III colon cancer (n=1095) and metastatic colorectal cancer (n=875). Descriptive statistical analyses were performed to evaluate anthropometrics, diet, and lifestyle in each cohort.

resultsMedian body mass index was comparable for stage III and metastatic patients (27.3 vs. 26.5 kg/m2). Stage III patients reported a modestly higher median level of physical activity than metastatic patients (4.6 vs. 3.4 metabolic equivalent task-hours per week). Ten percent of stage III and 9% of metastatic patients reported ongoing cigarette use. Avoidance of alcohol was reported by 47% of stage III and 43% of metastatic patients. Dietary patterns for both groups were comparable with more than 80% of stage III and metastatic patients failing to meet the recommended daily intake of vegetables, fruits, and milk products. Usage of at least 2 multivitamins per week was reported by 49% of stage III and 40% of metastatic patients. Two percent of stage III and 5% of metastatic patients reported vitamin D supplement use.

conclusionsWe observed notable similarities in dietary and lifestyle behaviors between stage III colon and metastatic colorectal cancer patients actively receiving chemotherapy. Future research should aim to elucidate the effect of these behaviors on patient outcomes.

Indexed as

Feeding BehaviorHealth BehaviorLife StyleAlcohol DrinkingCohort StudiesColorectal NeoplasmsDietary SupplementsHumansMotor ActivityNeoplasm MetastasisNeoplasm StagingNutrition PolicyPrevalenceSmokingSurveys and QuestionnairesVitamin DVitamin DVitamins

Identifiers

PMID23317558
PMCPMC3790266
OpenAlexW1978608893

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.